Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Gyre Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +3 vs. Q2 2023
- Shares held
- 2.15M
- −117.9K (−5.2%) vs. Q2 2023
- Total value
- $1.04M
- +$239.9K (+30.1%) vs. Q2 2023
- New holders
- 6
- 7 more added
- Sold out
- 3
- 8 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $57.1M |
| Q1 2026 | 56 | $23.8M |
| Q4 2025 | 44 | $23.6M |
| Q3 2025 | 48 | $23.1M |
| Q2 2025 | 48 | $25.1M |
| Q1 2025 | 46 | $20.1M |
| Q4 2024 | 41 | $21.6M |
| Q3 2024 | 37 | $20.2M |
| Q2 2024 | 30 | $15.0M |
| Q1 2024 | 21 | $14.3M |
| Q4 2023 | 16 | $15.6M |
| Q3 2023 | 32 | $1.04M |
| Q2 2023 | 29 | $796.3K |
| Q1 2023 | 40 | $707.6K |
| Q4 2022 | 35 | $2.63M |
| Q3 2022 | 35 | $3.90M |
| Q2 2022 | 41 | $14.2M |
| Q1 2022 | 43 | $6.39M |
| Q4 2021 | 51 | $13.7M |
| Q3 2021 | 66 | $75.7M |
| Q2 2021 | 69 | $87.7M |
| Q1 2021 | 89 | $113.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Gyre Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 590,687 | $285.0K | 0.00% | −183,699−23.7% | Reduced |
| Geode Capital Management, LLC | 258,746 | $124.8K | 0.00% | −11,287−4.2% | Reduced |
| Vanguard Group Inc | 206,900 | $99.8K | 0.00% | +206,900 | New |
| BlackRock Inc. | 153,759 | $74.2K | 0.00% | +102+0.1% | Added |
| Morgan Stanley | 97,745 | $47.1K | 0.00% | +21,647+28.4% | Added |
| Kynam Capital Management, LP | 90,058 | $43.4K | 0.01% | +172+0.2% | Added |
| Northern Trust Corp | 86,412 | $41.7K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 72,599 | $35.0K | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 67,800 | $32.7K | 0.00% | 00.0% | Unchanged |
| Johnson & Johnson | 66,951 | $32.3K | 0.01% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 63,793 | $30.0K | 0.00% | −80,235−55.7% | Reduced |
| Barclays PLC | 60,204 | $29.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 47,966 | $23.1K | 0.00% | +47,966 | New |
| Group One Trading, L.P. | 46,778 | $22.6K | 0.00% | −2,100−4.3% | Reduced |
| Parallax Volatility Advisers, L.P. | 43,804 | $21.1K | 0.00% | −15,549−26.2% | Reduced |
| Susquehanna International Group, LLP | 42,347 | $20.4K | 0.00% | −12,696−23.1% | Reduced |
| Colorado Capital Management, Inc. | 34,165 | $16.0K | 0.01% | 00.0% | Unchanged |
| HSBC Holdings PLC | 32,528 | $15.7K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 22,484 | $10.8K | 0.00% | −25,984−53.6% | Reduced |
| Two Sigma Securities, LLC | 20,039 | $9.66K | 0.00% | +20,039 | New |
| Raymond James & Associates | 12,900 | $6.22K | 0.00% | 00.0% | Unchanged |
| Arete Wealth Advisors, LLC | 10,845 | $5.23K | 0.00% | +10,845 | New |
| JPMorgan Chase & Co | 7,052 | $3.40K | 0.00% | +7,000+13,461.5% | Added |
| UBS Group AG | 5,079 | $2.45K | 0.00% | −20,904−80.5% | Reduced |
| Cutler Group LP | 5,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,017 | $1.94K | 0.00% | +2,732+212.6% | Added |
| Advisor Group Holdings, Inc. | 390 | $188 | 0.00% | +175+81.4% | Added |
| BNP Paribas Arbitrage, SA | 277 | $134 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 201 | $97 | 0.00% | +11+5.8% | Added |
| Qube Research & Technologies Ltd | 22 | $11 | 0.00% | +22 | New |
| GWM Advisors LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 253 | $0 | 0.00% | +253 | New |
| Virtu Financial LLC | 0 | $0 | 0.00% | −48,633−100.0% | Sold out |
| Keebeck Wealth Management, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −14,683−100.0% | Sold out |